Sutton Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sutton Wealth Advisors’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.07K	Hold	3	–	–	﹤0.01%	789
2023 Q2	$1.14K	Hold	3	–	–	﹤0.01%	767
2023 Q1	$1.44K	Hold	3	–	–	﹤0.01%	691
2022 Q4	$1.26K	Sell	3 -8	-73%	-$3.23K	﹤0.01%	1270
2022 Q3	$4.59K	Buy	11 +2	+22%	+$997	﹤0.01%	1088
2022 Q2	$4.46K	Buy	9 +8	+800%	+$4.17K	﹤0.01%	1078
2022 Q1	$563	Buy	+1	New	+$603	﹤0.01%	1465
2021 Q4	–	Sell	-3	Closed	-$2.24K	–	1672
2021 Q3	$2.24K	Buy	+3	New	+$2.25K	﹤0.01%	1157

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sutton Wealth Advisors's BIO Position: Q3 2023 in Review

Sutton Wealth Advisors held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2023 at 3 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Sutton Wealth Advisors first reported a position in BIO in Q3 2021 and has held it in 8 quarters since. The position peaked at $4.59K in Q3 2022. 468 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

Sutton Wealth Advisors held 3 shares of Bio-Rad Laboratories Class A worth $1.07K as of Q3 2023.
Sutton Wealth Advisors left its Bio-Rad Laboratories Class A share count unchanged in Q3 2023.
Bio-Rad Laboratories Class A made up ﹤0.01% of Sutton Wealth Advisors's portfolio in Q3 2023, its #789 holding.
Sutton Wealth Advisors first reported a position in Bio-Rad Laboratories Class A in Q3 2021 and has held it in 8 quarters since.
Sutton Wealth Advisors's Bio-Rad Laboratories Class A position peaked at $4.59K in Q3 2022.
468 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.